STATE STREET CORP - IRONWOOD PHARMACEUTICALS INC ownership

IRONWOOD PHARMACEUTICALS INC's ticker is IRWD and the CUSIP is 46333X108. A total of 250 filers reported holding IRONWOOD PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.84 and the average weighting 0.1%.

Quarter-by-quarter ownership
STATE STREET CORP ownership history of IRONWOOD PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$115,529,810
-1.5%
11,996,865
+8.8%
0.01%0.0%
Q2 2023$117,343,123
+6.4%
11,028,489
+5.2%
0.01%0.0%
Q1 2023$110,268,978
-60.2%
10,481,842
-53.1%
0.01%
-25.0%
Q4 2022$277,029,942
+133.5%
22,359,156
+95.2%
0.01%0.0%
Q3 2022$118,665,000
-5.5%
11,454,170
+5.2%
0.01%0.0%
Q2 2022$125,525,000
+20.3%
10,886,805
+31.2%
0.01%
+60.0%
Q1 2022$104,377,000
+13.6%
8,297,067
+5.3%
0.01%
+25.0%
Q4 2021$91,861,000
-5.4%
7,878,311
+6.0%
0.00%
-20.0%
Q3 2021$97,075,000
+10.8%
7,433,009
+9.2%
0.01%0.0%
Q2 2021$87,589,000
+6.2%
6,805,669
-7.8%
0.01%0.0%
Q1 2021$82,509,000
-4.5%
7,380,026
-2.7%
0.01%0.0%
Q4 2020$86,386,000
+20.3%
7,584,369
-5.0%
0.01%0.0%
Q3 2020$71,818,000
-15.5%
7,984,250
-3.0%
0.01%
-16.7%
Q2 2020$84,981,000
+43.9%
8,234,563
+40.7%
0.01%
+20.0%
Q1 2020$59,053,000
-23.2%
5,852,637
+1.4%
0.01%0.0%
Q4 2019$76,858,000
+53.6%
5,774,445
-0.9%
0.01%
+25.0%
Q3 2019$50,023,000
-25.5%
5,826,773
-5.1%
0.00%
-20.0%
Q2 2019$67,143,000
-11.0%
6,137,412
+10.1%
0.01%
-16.7%
Q1 2019$75,424,000
+36.1%
5,574,548
+4.2%
0.01%
+20.0%
Q4 2018$55,436,000
-44.6%
5,350,925
-1.3%
0.01%
-37.5%
Q3 2018$100,067,000
-5.5%
5,420,669
-2.1%
0.01%
-11.1%
Q2 2018$105,884,000
+13.7%
5,537,623
-8.2%
0.01%
+12.5%
Q1 2018$93,090,000
+28.6%
6,033,070
+24.9%
0.01%
+33.3%
Q4 2017$72,371,000
+1.0%
4,828,511
+6.2%
0.01%0.0%
Q3 2017$71,677,000
-16.2%
4,545,193
+0.3%
0.01%
-25.0%
Q2 2017$85,533,000
+25.8%
4,530,267
+13.7%
0.01%
+33.3%
Q1 2017$67,979,000
+17.3%
3,984,803
+5.1%
0.01%
+20.0%
Q4 2016$57,972,000
+6.5%
3,791,359
+10.6%
0.01%0.0%
Q3 2016$54,440,000
+28.9%
3,427,936
+6.2%
0.01%0.0%
Q2 2016$42,222,000
+26.7%
3,229,227
+6.0%
0.01%
+25.0%
Q1 2016$33,321,000
-15.2%
3,045,704
-10.2%
0.00%0.0%
Q4 2015$39,316,000
-7.4%
3,392,238
-16.7%
0.00%
-20.0%
Q3 2015$42,455,000
-13.1%
4,074,629
+0.6%
0.01%0.0%
Q2 2015$48,846,000
-9.1%
4,050,198
+20.6%
0.01%
-16.7%
Q1 2015$53,730,000
+18.3%
3,357,894
+13.2%
0.01%
+20.0%
Q4 2014$45,436,000
+17.1%
2,965,658
-1.0%
0.01%
+25.0%
Q3 2014$38,812,000
-9.0%
2,996,085
+7.7%
0.00%
-20.0%
Q2 2014$42,662,000
+10.0%
2,782,787
-11.6%
0.01%
+25.0%
Q1 2014$38,787,000
-33.6%
3,148,354
-38.7%
0.00%0.0%
Q4 2013$58,457,000
+59.0%
5,132,820
+65.5%
0.00%
-20.0%
Q3 2013$36,756,000
+23.1%
3,101,326
+3.3%
0.01%
+25.0%
Q2 2013$29,869,0003,001,3570.00%
Other shareholders
IRONWOOD PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
HealthInvest Partners AB 1,520,000$19,562,00018.54%
Sarissa Capital Management LP 16,390,000$210,939,00016.77%
Healthcare Value Capital, LLC 200,000$2,574,0005.13%
Camber Capital Management LP 7,500,000$96,525,0003.25%
13D Management LLC 650,455$8,371,0002.88%
BRIDGER MANAGEMENT, LLC 2,035,114$26,192,0002.44%
Brown Capital Management 18,484,759$237,899,0001.80%
Healthcare Value Capital, LLC 50,000$644,0001.28%
Zebra Capital Management LLC 53,359$687,0000.80%
PRICE MICHAEL F 520,000$6,692,0000.74%
View complete list of IRONWOOD PHARMACEUTICALS INC shareholders